SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.46+1.6%12:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (13666)5/26/2000 11:00:00 AM
From: aknahow  Read Replies (1) of 17367
 
E.Coli revisited. Cacaito, please don't lurk, but rather help out one more time.

XOMA reports the following rBPI21 synergizes with Ceftriaxone to kill kill cefttriaxone resistant organisms. EC 004. EC 600 and EC 664.

Another graph is titled rBPI Kills Rough and Smooth Strains of E.Coli and shows rBPI21 and rBPI23 killinf E.coli J5 and E. coli 07:k1

Since I have nothing specific on 0157 I do not know what it does for this strain. Again XOMA is talking about killing not binding to endotoxin. Understand your exotoxin point and if that is the main problem with 0157 then killing may not be enough.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext